Literature DB >> 17111187

Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma.

Carmen S P Lima1, Helvia Nascimento, Luciana C Bonadia, Maria T Teori, Claudio S R Coy, Juvenal R N Góes, Fernando F Costa, Carmen S Bertuzzo.   

Abstract

BACKGROUND AND AIMS: Evidence is accumulating for a role of folate in the aetiology of colorectal cancer (CRC). The methylenetetrahydrofolate reductase (MTHFR) gene, involved in folate metabolism, is polymorphic in humans. Since it is unknown whether the MTHFR C677T and A1298C polymorphisms alter the risk for CRC, this was the aim of our study.
MATERIALS AND METHODS: Genomic DNA from 102 sporadic colorectal adenocarcinoma (SCA) patients and 300 controls was analyzed by polymerase chain reaction followed by restriction digestion for the polymorphisms analyses. RESULTS/
FINDINGS: The frequencies of MTHFR C677T and A1298C genotypes were similar in patients and controls. Similar overall risks for disease were seen in individuals with the distinct MTHFR genotypes. However, an excess of the MTHFR 677TT and 677CT genotypes was seen in patients under 50 years, compared with patients at an older age (19.2 vs 13.1% and 61.6 vs 39.5%, respectively; P = 0.04). The differences were more prominent when the frequency of the 677TT plus 677CT genotype was seen in both group of patients (80.8 vs 52.6%, respectively; P = 0.01), and in younger patients compared to controls (80.8 vs 52.3%, P < 0.01). Individuals with the combined genotype had 3.82-fold (95% confidence interval, 1.41-10.42) increased risk of developing SCA under 50 years, compared with those harboring the wild-type genotype. INTERPRETATION/
CONCLUSION: These results suggest a role for the MTHFR 677TT plus 677CT genotype in increasing SCA diagnosed at a low age in southeastern Brazil, but additional studies with larger sample sizes should be carried out to clarify this issue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111187     DOI: 10.1007/s00384-006-0237-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.796


  39 in total

1.  The phylogeography of Brazilian Y-chromosome lineages.

Authors:  D R Carvalho-Silva; F R Santos; J Rocha; S D Pena
Journal:  Am J Hum Genet       Date:  2000-11-22       Impact factor: 11.025

2.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

3.  [677T mutation of the MTHFR gene in adenomas and colorectal cancer in a population sample from the Northeastern Mexico. Preliminary results].

Authors:  I Delgado-Enciso; S G Martínez-Garza; A Rojas-Martínez; R Ortiz-López; F Bosques-Padilla; A L Calderón-Garcidueñas; M Zárate-Gómez; H A Barrera-Saldaña
Journal:  Rev Gastroenterol Mex       Date:  2001 Jan-Mar

4.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

5.  Relationship between metabolic enzyme polymorphism and colorectal cancer.

Authors:  Kun Chen; Qin-Ting Jiang; Han-Qing He
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

6.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

7.  Hypomethylation in cervical tissue: is there a correlation with folate status?

Authors:  B M Fowler; A R Giuliano; C Piyathilake; M Nour; K Hatch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-10       Impact factor: 4.254

8.  5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.

Authors:  Temitope Keku; Robert Millikan; Kendra Worley; Scott Winkel; Allison Eaton; Lorna Biscocho; Christopher Martin; Robert Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

9.  Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis?

Authors:  V R Arruda; C E Grignolli; M S Gonçalves; M C Soares; R Menezes; S T Saad; F F Costa
Journal:  Clin Genet       Date:  1998-09       Impact factor: 4.438

10.  The relationship between smoking exposure and p53 overexpression in colorectal cancer.

Authors:  A N Freedman; A M Michalek; J R Marshall; C J Mettlin; N J Petrelli; Z F Zhang; J D Black; S Satchidanand; J E Asirwatham
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

View more
  15 in total

1.  MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.

Authors:  Xuewen Sheng; Yanxi Zhang; Erjiang Zhao; Su Lu; Xiaoli Zheng; Hong Ge; Weiquan Lu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

2.  A comparison of approaches for association studies of polymorphisms and colorectal cancer risk.

Authors:  S D Ramsey; R S Holmes; C L McDermott; D K Blough; K L Petrin; E M Poole; C M Ulrich
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

3.  MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer.

Authors:  Yvonne Wettergren; Elisabeth Odin; Göran Carlsson; Bengt Gustavsson
Journal:  Mol Med       Date:  2010-06-11       Impact factor: 6.354

4.  Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma.

Authors:  José Luiz Miranda Guimarães; Maria de Lurdes Ayrizono; Cláudio Saddy Rodrigues Coy; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2011-05-21

5.  Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.

Authors:  Antonia M Fernández-Peralta; Lydia Daimiel; Nargisse Nejda; Daniel Iglesias; Vicente Medina Arana; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2009-08-11       Impact factor: 2.571

6.  Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability.

Authors:  Luciano Delgado-Plasencia; Vicente Medina-Arana; Alberto Bravo-Gutiérrez; Julián Pérez-Palma; Hugo Álvarez-Argüelles; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2013-02-20       Impact factor: 2.571

Review 7.  Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

Authors:  E Taioli; M A Garza; Y O Ahn; D T Bishop; J Bost; B Budai; K Chen; F Gemignani; T Keku; C S P Lima; L Le Marchand; K Matsuo; V Moreno; J Plaschke; M Pufulete; S B Thomas; G Toffoli; C R Wolf; C G Moore; J Little
Journal:  Am J Epidemiol       Date:  2009-10-21       Impact factor: 4.897

8.  Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: A meta-analysis.

Authors:  Mengmeng Zhao; Xuelian Li; Chengzhong Xing; Baosen Zhou
Journal:  Biomed Rep       Date:  2013-07-15

9.  The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.

Authors:  Daijun Zhou; Qiang Mei; Han Luo; Bo Tang; Peiwu Yu
Journal:  Int J Biol Sci       Date:  2012-06-08       Impact factor: 6.580

10.  [Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of sporadic colorectal cancer].

Authors:  Imane Baghad; Driss Erreguibi; Rachid Boufettal; Saad Rifki Eljai; Farid Chihab; Sellama Nadifi
Journal:  Pan Afr Med J       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.